Screener
Orchestra BioMed Holdings, Inc. OBIO Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$836.0KBeat by $57.2K
EPS-$0.50Beat by $0.01
Revenue estimate$778.8K
EPS estimate-$0.51
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q2 2025 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Orchestra BioMed Holdings, Inc.'s Q2 2025 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $836.0K and eps of $-0.50 for Q2 2025.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $778.8K by $57.2K. EPS beat the consensus estimate of $-0.51 by $0.01.
- How did Orchestra BioMed Holdings, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.5% from $778.0K a year earlier and eps declined 11.1% from $-0.45.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-011148) directly on SEC EDGAR. The filing index links above go to sec.gov.
